Insider · CIK 0001859559
Mark Locke
Files at GENI (Genius Sports Ltd). First filing Sep 17, 2026, latest Sep 17, 2026.
In brief
Mark Locke files SEC Form 4 as CEO and director at GENI (Genius Sports Ltd). Since Sep 17, 2026, Mark Locke has reported 0 open-market buys worth $0 and 1 open-market sell worth $5.3M, the latest filed on Sep 17, 2026.
A track record needs three past buys with six months of prices behind them; Mark Locke has 0, so none is measured yet.
The newest scored trade: sold $5.3M of GENI on Sep 15, 2026, filed Sep 17, 2026, scored 58 (moderate). In the last 12 months: 0 buys worth $0 and 1 sell worth $5.3M.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
GENI: Genius Sports Ltd
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 58Moderate | Genius Sports Ltd | $5.3M 800,000 shares | -4% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Jan 7, 2026 | GENI Genius Sports Ltd | 53,679 0.03% of outstanding | $556k | Jan 7, 2026 | $2.4M |
| Jan 6, 2026 | GENI Genius Sports Ltd | 91,724 0.04% of outstanding | $995k | Jan 6, 2026 | $1.4M |
| Nov 10, 2025 | GENI Genius Sports Ltd | 131,608 0.06% of outstanding | $1.4M | Nov 10, 2025 | none |
| Jan 8, 2025 | GENI Genius Sports Ltd | 8,661 0.00% of outstanding | $77k | Jan 8, 2025 | $292k |
| Jan 7, 2025 | GENI Genius Sports Ltd | 31,753 0.01% of outstanding | $292k | Jan 7, 2025 | none |
Transactions
Every row this insider has filed, 8 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 15, 2026 | GENI Genius Sports Ltd | SOpen-market sale Ordinary Shares | -477,449 | $6.58 | $3.1M | 19,697,767 | 26 d ago |
| Sep 16, 2026 | GENI Genius Sports Ltd | SOpen-market sale Ordinary Shares | -272,551 | $6.56 | $1.8M | 19,425,216 | 26 d ago |
| Sep 17, 2026 | GENI Genius Sports Ltd | SOpen-market sale Ordinary Shares | -50,000 | $6.54 | $327k | 19,375,216 | 26 d ago |
| Sep 15, 2026 | GENI Genius Sports Ltd | SOpen-market sale Call Option (obligation to sell)derivative | -1 | - | - | 1 | 26 d ago |
| Sep 15, 2026 | GENI Genius Sports Ltd | POpen-market purchase Put Option (right to sell)derivative | +1 | - | - | 1 | 26 d ago |
| Mar 20, 2026 | GENI Genius Sports Ltd | MOption exercise Ordinary Shares | +120,000 | - | - | 20,183,016 | Mar 24, 2026 |
| Mar 20, 2026 | GENI Genius Sports Ltd | FTax withholding Ordinary Shares | -7,800 | $4.53 | $35k | 20,175,216 | Mar 24, 2026 |
| Mar 20, 2026 | GENI Genius Sports Ltd | MOption exercise Restricted Share Units (May 2025)derivative | -120,000 | $0.00 | $0 | 0 | Mar 24, 2026 |
Questions about Mark Locke
Answered from the filings on this page, as of the latest one.
Is Mark Locke buying or selling?
In the last 12 months Mark Locke reported 0 open-market buys worth $0 and 1 open-market sell worth $5.3M on SEC Form 4; the latest was sold $5.3M of GENI on Sep 15, 2026. Grants, option exercises and tax withholding are not counted.
How did Mark Locke's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Mark Locke has 0.
Where does Mark Locke file Form 4?
Mark Locke has filed Form 4 at GENI (Genius Sports Ltd) as Chief Executive Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.